181 related articles for article (PubMed ID: 36211587)
1. Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function.
Sanchez-Gimenez R; Peiró ÓM; Bonet G; Carrasquer A; Fragkiadakis GA; Bulló M; Papandreou C; Bardaji A
Front Cardiovasc Med; 2022; 9():1000815. PubMed ID: 36211587
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
Amrein M; Li XS; Walter J; Wang Z; Zimmermann T; Strebel I; Honegger U; Leu K; Schäfer I; Twerenbold R; Puelacher C; Glarner N; Nestelberger T; Koechlin L; Ceresa B; Haaf P; Bakula A; Zellweger M; Hazen SL; Mueller C
Clin Res Cardiol; 2022 Jun; 111(6):692-704. PubMed ID: 35220448
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.
Wang Z; Tang WH; Buffa JA; Fu X; Britt EB; Koeth RA; Levison BS; Fan Y; Wu Y; Hazen SL
Eur Heart J; 2014 Apr; 35(14):904-10. PubMed ID: 24497336
[TBL] [Abstract][Full Text] [Related]
6. Trimethylamine N-oxide, choline and its metabolites are associated with the risk of non-alcoholic fatty liver disease.
Ma R; Shi G; Li Y; Shi H
Br J Nutr; 2024 Jun; 131(11):1915-1923. PubMed ID: 38443197
[TBL] [Abstract][Full Text] [Related]
7. Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study.
Papandreou C; Bulló M; Hernández-Alonso P; Ruiz-Canela M; Li J; Guasch-Ferré M; Toledo E; Clish C; Corella D; Estruch R; Ros E; Fitó M; Alonso-Gómez A; Fiol M; Santos-Lozano JM; Serra-Majem L; Liang L; Martínez-González MA; Hu FB; Salas-Salvadó J
Clin Chem; 2021 Jan; 67(1):288-297. PubMed ID: 33257943
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
Mueller DM; Allenspach M; Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A
Atherosclerosis; 2015 Dec; 243(2):638-44. PubMed ID: 26554714
[TBL] [Abstract][Full Text] [Related]
9. Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults.
Fretts AM; Hazen SL; Jensen P; Budoff M; Sitlani CM; Wang M; de Oliveira Otto MC; DiDonato JA; Lee Y; Psaty BM; Siscovick DS; Sotoodehnia N; Tang WHW; Lai H; Lemaitre RN; Mozaffarian D
JAMA Netw Open; 2022 May; 5(5):e2213242. PubMed ID: 35594043
[TBL] [Abstract][Full Text] [Related]
10. TCA cycle metabolites associated with adverse outcomes after acute coronary syndrome: mediating effect of renal function.
Sanchez-Gimenez R; Peiró ÓM; Bonet G; Carrasquer A; Fragkiadakis GA; Bulló M; Papandreou C; Bardaji A
Front Cardiovasc Med; 2023; 10():1157325. PubMed ID: 37441709
[TBL] [Abstract][Full Text] [Related]
11. Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health Study.
Lemaitre RN; Jensen PN; Wang Z; Fretts AM; McKnight B; Nemet I; Biggs ML; Sotoodehnia N; de Oliveira Otto MC; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
JAMA Netw Open; 2021 Aug; 4(8):e2122844. PubMed ID: 34448864
[TBL] [Abstract][Full Text] [Related]
12. Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes.
Li XS; Obeid S; Wang Z; Hazen BJ; Li L; Wu Y; Hurd AG; Gu X; Pratt A; Levison BS; Chung YM; Nissen SE; Tang WHW; Mach F; Räber L; Nanchen D; Matter CM; Lüscher TF; Hazen SL
Eur Heart J; 2019 Aug; 40(32):2700-2709. PubMed ID: 31049589
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.
Heianza Y; Ma W; Manson JE; Rexrode KM; Qi L
J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28663251
[TBL] [Abstract][Full Text] [Related]
14. Plasma Concentrations of Trimethylamine-N-Oxide, Choline, and Betaine in Patients With Moderate to Advanced Chronic Kidney Disease and Their Relation to Cardiovascular and Renal Outcomes.
Obeid R; Awwad H; Heine GH; Emrich IE; Fliser D; Zawada AM; Geisel J
J Ren Nutr; 2024 Apr; ():. PubMed ID: 38621431
[TBL] [Abstract][Full Text] [Related]
15. Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort.
Wargny M; Croyal M; Ragot S; Gand E; Jacobi D; Trochu JN; Prieur X; Le May C; Goronflot T; Cariou B; Saulnier PJ; Hadjadj S;
Cardiovasc Diabetol; 2022 Jun; 21(1):101. PubMed ID: 35681209
[TBL] [Abstract][Full Text] [Related]
16. Choline metabolites and incident cardiovascular disease in a prospective cohort of adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Shea JW; Jacobs DR; Howard AG; Lulla A; Lloyd-Jones DM; Murthy VL; Shah RV; Trujillo-Gonzalez I; Gordon-Larsen P; Meyer KA
Am J Clin Nutr; 2024 Jan; 119(1):29-38. PubMed ID: 37865185
[TBL] [Abstract][Full Text] [Related]
17. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
[TBL] [Abstract][Full Text] [Related]
18. Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study.
Lever M; George PM; Slow S; Bellamy D; Young JM; Ho M; McEntyre CJ; Elmslie JL; Atkinson W; Molyneux SL; Troughton RW; Frampton CM; Richards AM; Chambers ST
PLoS One; 2014; 9(12):e114969. PubMed ID: 25493436
[TBL] [Abstract][Full Text] [Related]
19. Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes.
Croyal M; Saulnier PJ; Aguesse A; Gand E; Ragot S; Roussel R; Halimi JM; Ducrocq G; Cariou B; Montaigne D; Wargny M; Krempf M; Hadjadj S
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32301490
[TBL] [Abstract][Full Text] [Related]
20. Association between trimethylamine N-oxide and prognosis of patients with acute myocardial infarction and heart failure.
Li N; Zhou J; Wang Y; Chen R; Li J; Zhao X; Zhou P; Liu C; Song L; Liao Z; Wang X; Yan S; Zhao H; Yan H
ESC Heart Fail; 2022 Dec; 9(6):3846-3857. PubMed ID: 35686339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
